Actinobac Biomed raised a round of funding on October 14, 2014. Investors include National Cancer Institute.
Actinobac Biomed is a biopharmaceutical company developing therapeutics for multiple indications, including blood cancers, autoimmune/inflammatory diseases, and HIV. Its drug candidates are based upon…
